These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11741470)

  • 1. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Lastres-Becker I; González S; Fernández-Ruiz J; Ramos JA
    J Med Chem; 2001 Dec; 44(26):4505-8. PubMed ID: 11741470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    Eur J Med Chem; 2003 Apr; 38(4):403-12. PubMed ID: 12750028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
    Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
    Breivogel CS; Griffin G; Di Marzo V; Martin BR
    Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.
    de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Viso A; López-Rodríguez ML; Ramos JA
    Eur J Pharmacol; 2002 Aug; 449(1-2):99-103. PubMed ID: 12163112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.
    Jarrahian A; Manna S; Edgemond WS; Campbell WB; Hillard CJ
    J Neurochem; 2000 Jun; 74(6):2597-606. PubMed ID: 10820223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V; Bisogno T; De Petrocellis L; Brandi I; Jefferson RG; Winckler RL; Davis JB; Dasse O; Mahadevan A; Razdan RK; Martin BR
    Biochem Biophys Res Commun; 2001 Feb; 281(2):444-51. PubMed ID: 11181068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the synthesis of endocannabinoid related ligands.
    Razdan RK; Mahadevan A
    Chem Phys Lipids; 2002 Dec; 121(1-2):21-33. PubMed ID: 12505687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.
    Ford WR; Honan SA; White R; Hiley CR
    Br J Pharmacol; 2002 Mar; 135(5):1191-8. PubMed ID: 11877326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid.
    Wise ML; Soderstrom K; Murray TF; Gerwick WH
    Experientia; 1996 Jan; 52(1):88-92. PubMed ID: 8575565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
    Schmid HH; Schmid PC; Berdyshev EV
    Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and behavioral evaluation of alkylated anandamide analogs.
    Adams IB; Ryan W; Singer M; Razdan RK; Compton DR; Martin BR
    Life Sci; 1995; 56(23-24):2041-8. PubMed ID: 7776830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.